Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.

Slides:



Advertisements
Similar presentations
CROMS NIDCR Clinical Monitoring
Advertisements

Tips to a Successful Monitoring Visit
The HRPP FYI Process and the UPIRSO/SAE Review Sheet An IRB Infoshort February 2014.
Chicken Soup for the Busy Coordinator
How to Survive an FDA Inspection
HELP! The FDA is Coming! Margaret M. Groves, JD, CRA Director, Clinical Trials Quality Assurance (CTQA) School of Medicine (SOM) Compliance Office.
Content of Regulatory/Study Binder Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff.
Research Coordination Guidance The Committees on Human Research Serving University of Vermont & Fletcher Allen Health Care
Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
The IND and Clinical Trial Management Frances Richmond Director International Center for Clinical Trials.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
MONITORING DIFFERENT TYPES OF TRIALS. BY OGUNDOKUN OLUSEGUN BIOMEDICAL SCIENTIST / CLINICAL RESEARCH PROFESSIONAL BMLS (LAUTECH), PGD (Clin. Research.
Guideline for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Clinical Trials Support Unit (CTSU) Lore Lagrone Program.
Good Clinical Practice in Research
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
Institutional Review Board (IRB) Human Subject Research Office (HSRO) University of Miami and Affiliated Institutions.
Monitoring and Special Considerations for Multi-Center Trials
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
1 NJ Dept. of Health Decision Tree for eIRB Submission Revised: 06/18/2015 Is this research defined as: A systematic investigation which includes research.
Carolyn Hommel Good Clinical Practice Program FDA February 25, 2004
Using Technology to Strengthen Human Subject Protections Patricia Scannell Director, IRB Washington University School of Medicine.
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
Audits and Inspections in Clinical Research Jobin Kunjumon Vilapurathu.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
RESPONSIBILITIES OF INVESTIGATOR
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
New IRB Guideline Changes and Converting to eIRB - Suggestions for Maintaining Compliance. Ramesh Ghodgaonkar, BPHARM, MSITS, MSB, MBA Betsy Johnson, BA.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Research Studies GOTCHA’S By Sally Duffy. Failure to follow protocol, investigator agreements and regulations Did not use device/drug in manner specified.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
Read the SMALL PRINT of the 1572 The Essential GCP Document.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
Investigational Devices and Humanitarian Use Devices June 2007.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
Sponsor Visits and Monitoring
Non-compliance with Human Subjects Research Regulations J. Bruce Smith, MD, CIP November 2014 Continuing Education for IRB Members.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Lifespan 1 Submission Process to the IRB part 2 Revisions to Protocol.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
Site Set-up and Conduct Caroline O’Leary and Carrie Bayliss.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Supervisory Responsibilities of Clinical Investigators
Good Clinical Practice (GCP) and Monitoring Practices
The Role and Responsibilities of the Clinical Research Coordinator
Responsibilities of Sponsor, Investigator and Monitor
How to prepare for an Audit
IRB reporting updates.
Reportable Events & Other IRB Updates February 2017
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Elements of an Organized Regulatory Binder
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Understanding the Process of Documenting Informed Consent
Good clinical practice
Presentation transcript:

Monitoring IRB Monitoring of Clinical Trials

Types of Monitoring Internally Internally Externally Externally

Which Protocols are Monitored? All protocols reviewed by the IRB are subject to regulatory monitoring by IRB personnel; All protocols reviewed by the IRB are subject to regulatory monitoring by IRB personnel; A random list is generated yearly by the IRB Information Systems Specialist of active protocols for monitoring; A random list is generated yearly by the IRB Information Systems Specialist of active protocols for monitoring; In addition, protocols are monitored for- cause. In addition, protocols are monitored for- cause.

Types of Studies Selected Investigator-initiated studies; Investigator-initiated studies; Investigator-held IND/IDE studies; Investigator-held IND/IDE studies; High-risk studies designated by the IRB; High-risk studies designated by the IRB; At the request of the IRB; At the request of the IRB; For cause; For cause; Studies conducted by investigators with prior 483 Inspectional Observations or warning letters from the FDA; Studies conducted by investigators with prior 483 Inspectional Observations or warning letters from the FDA; Studies with a large number of SAEs or protocol deviations reported; Studies with a large number of SAEs or protocol deviations reported; High enrollment studies; High enrollment studies; Outside monitoring reports from sponsors received by the OIRB indicating deficiencies; Outside monitoring reports from sponsors received by the OIRB indicating deficiencies; At the request of and in conjunction with the UAB Research Compliance Office. At the request of and in conjunction with the UAB Research Compliance Office.

Investigator Responsibilities Responds promptly to requests by the OIRB for arranging audit of the regulatory files; Responds promptly to requests by the OIRB for arranging audit of the regulatory files; Provides a quiet area for the records review; Provides a quiet area for the records review; Is available, along with study coordinator, during the review to answer questions; Is available, along with study coordinator, during the review to answer questions; Responds promptly, in writing, to requests by the OIRB monitor; Responds promptly, in writing, to requests by the OIRB monitor; Submits a corrective action plan, in writing, within 30 days, if requested. Submits a corrective action plan, in writing, within 30 days, if requested.

OIRB Monitor Responsibilities Schedules appointment for regulatory monitoring with the investigator and study coordinator usually 2 to 4 days in advance of visit; Schedules appointment for regulatory monitoring with the investigator and study coordinator usually 2 to 4 days in advance of visit; Sends follow-up written communication confirming appointment and list of pertinent study materials that should be available for the reviewer as well as any issues that need to be specifically addressed; Sends follow-up written communication confirming appointment and list of pertinent study materials that should be available for the reviewer as well as any issues that need to be specifically addressed; Meets with the study coordinator and principal investigator, if needed; Meets with the study coordinator and principal investigator, if needed;

OIRB Monitor Responsibilities Completes monitoring report forms within 2 weeks of audit; Completes monitoring report forms within 2 weeks of audit; Sends copy of the report to the PI; Sends copy of the report to the PI; Schedules the report for the next convened IRB meeting; Schedules the report for the next convened IRB meeting; Re-audits in 6 months if audit reveals deficiencies that are unacceptable. Re-audits in 6 months if audit reveals deficiencies that are unacceptable.

What is Reviewed and Verified? Study protocol approved; Study protocol approved; Continuing reviews submitted prior to expiration of approval; Continuing reviews submitted prior to expiration of approval; Screening and enrollment logs accurate and up to date; Screening and enrollment logs accurate and up to date; IRB approval obtained prior to participant enrollment; IRB approval obtained prior to participant enrollment; Valid informed consent documents were used; Valid informed consent documents were used; Original signed informed consent documents appropriately executed; Original signed informed consent documents appropriately executed; Addendum informed consent documents signed, if applicable; Addendum informed consent documents signed, if applicable; Adherence to study protocol; Adherence to study protocol;

Modifications to the protocol and informed consent document submitted to the IRB and approved prior to initiation; Modifications to the protocol and informed consent document submitted to the IRB and approved prior to initiation; Accurate, complete and current records being maintained; Accurate, complete and current records being maintained; Timely, accurate, and complete reporting of serious adverse events and protocol deviations to the sponsor and the UAB IRB; Timely, accurate, and complete reporting of serious adverse events and protocol deviations to the sponsor and the UAB IRB; Qualified investigators/study personnel conducting study activities; Qualified investigators/study personnel conducting study activities; Principal investigator carrying out the agreed upon activities and not delegating them to other staff not previously identified; Principal investigator carrying out the agreed upon activities and not delegating them to other staff not previously identified; Records maintained appropriately. Records maintained appropriately. What is Reviewed and Verified?

IRB Responsibilities Reviews monitoring reports at a convened meeting; Reviews monitoring reports at a convened meeting; Makes a determination to accept the report; Makes a determination to accept the report; Takes action, if indicated and determined to be necessary, based on the report. Takes action, if indicated and determined to be necessary, based on the report.

Questions?